Photo of Krysten Rosen Moller

Krysten Rosen Moller practices in the areas of health care, litigation, pharmaceutical investigations, and white collar defense and investigations. Ms. Rosen Moller primarily helps pharmaceutical and medical device companies with internal investigations, and civil and criminal investigations by the DOJ, FDA, HHS, and other agencies, relating to fraud, marketing, kickbacks, manufacturing practices, and false claims. Ms. Rosen Moller also provides advice on developments in, and compliance with, health care laws.

On October 31, 2014, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) released its Work Plan for fiscal year 2015.  Appendix B of the Work Plan outlines OIG’s plans for continued oversight of HHS agencies’ use of American Recovery and Reinvestment Act of 2009 (Recovery Act) funds.
Continue Reading Recovery Act Reviews Outlined in HHS OIG’s Work Plan for Fiscal Year 2015 Focus on EHR Incentive Payments

On November 4, 2014, Health and Human Services (HHS) Secretary Sylvia M. Burwell named a new member to the Health Information Technology Policy Committee (HITPC) and renewed appointments for three members of the Health Information Technology Standards Committee (HITSC).
Continue Reading HHS Secretary Names Members for Health Information Technology Policy Committee and Health Information Technology Standards Committee

On October 14, 2014, the American Medical Association (AMA) outlined its vision for the Electronic Health Record (EHR) Meaningful Use (MU) Program in a letter to the Centers for Medicare & Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology.  Despite the MU program’s achievements since its creation in 2009, the AMA believes “it is important and necessary to pause and fully assess what is working and what needs improvement before moving ahead to Stage 3 of the program.” 
Continue Reading AMA Recommends Improvements to Meaningful Use Program